Vaccines and other biomedical advances will not be sufficient to halt COVID-19, unless we simultaneously counter anti-science aggression, writes Peter Hotez, fellow in disease and poverty, in a new article for PLOS Biology: http://bit.ly/3oL5dLx
Feb. 3, 2021, 3:08 p.m.
Deepak Srivastava, M.D., is the Baker Institute Nonresident Scholar for Biomedical Research Policy. He is the Younger Family Director and senior investigator at the Gladstone Institute of Cardiovascular Disease, as well as director of Gladstone’s Roddenberry Stem Cell Center. At …
Zubin Master, Ph.D., is a nonresident scholar in the Center for Health and Biosciences. He is an associate professor of biomedical ethics at the Biomedical Ethics Research Program and the Center for Regenerative Medicine at Mayo Clinic in …
November 11, 2021
As U.S. health care costs continue their relentless rise, much of the cost is passed …
